Blood protein may reveal clues about ankylosing spondylitis

NCT ID NCT07117344

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at a protein called progranulin in the blood of people with ankylosing spondylitis (a type of arthritis that affects the spine) and compares it to healthy volunteers. Researchers want to see if progranulin levels are linked to disease activity and whether they change with TNF-α inhibitor treatment. The goal is to find a new biomarker that could help monitor the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) / RADIOGRAPHIC AXIAL SPA (R-AXSPA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kırşehir Ahi Evran University

    Kırşehir, 40100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.